A tragic and preventable death has sparked a crucial debate about patient safety in the UK. A 15-year-old boy’s life was cut short after being sedated with Propofol for six days, and now a coroner is demanding nationwide rules to prevent similar tragedies. But here’s where it gets controversial: despite known risks, there’s still no national guidance on how this powerful sedative should be used.
Antonio Galisi-Swallow, a vibrant teenager with Down Syndrome, attention deficit hyperactivity disorder, autism, and a congenital heart defect, died at Leeds General Infirmary (LGI) in October 2021. He had been admitted for heart surgery, a procedure meant to improve his quality of life. Instead, he was placed on a continuous infusion of Propofol for post-operative sedation. Days later, he developed a persistent fever, acute kidney injury, and ultimately went into cardiac arrest. An inquest revealed that his death was directly linked to Propofol-Related Infusion Syndrome (PRIS), a rare but serious condition associated with prolonged use of the drug.
And this is the part most people miss: Leeds Teaching Hospitals NHS Trust has since developed new guidelines for Propofol use in children, which experts believe could have saved Antonio’s life. But why wasn’t this guidance in place sooner? Coroner Oliver Longstaff has raised the alarm, warning that without national standards, more lives could be at risk. In his report to the National Institute for Health and Care Excellence (NICE), he emphasized the urgent need for consistent protocols across the UK.
Antonio’s mother, Milena Galisi, shared her heartbreak: ‘He went into hospital as a healthy, happy boy for a planned procedure that was supposed to make his life better. Instead, I watched him suffer for days, and my concerns were ignored.’ Her words highlight a devastating reality: families are left to grieve what could have been, had proper precautions been taken.
Beatrice Morgan, a human rights solicitor representing Antonio’s family, called his death ‘entirely preventable.’ She pointed out that clinicians were aware of the risks of prolonged Propofol use but failed to explore safer alternatives. ‘The expert evidence is clear,’ she said. ‘Antonio died from Propofol Infusion Syndrome, and it didn’t have to happen.’
Here’s the controversial question: Should hospitals be held more accountable for adopting best practices before tragedies occur? Or is it the government’s responsibility to enforce stricter regulations? The lack of national guidelines leaves room for interpretation and potential errors, putting vulnerable patients like Antonio at risk.
As the debate continues, one thing is certain: Antonio’s story is a stark reminder of the consequences when medical protocols fall short. What do you think? Should there be stricter rules around Propofol use, or is this an isolated incident? Share your thoughts in the comments—this is a conversation that needs to happen.
